NO20030019L - Human Myelom-cellelinje - Google Patents

Human Myelom-cellelinje

Info

Publication number
NO20030019L
NO20030019L NO20030019A NO20030019A NO20030019L NO 20030019 L NO20030019 L NO 20030019L NO 20030019 A NO20030019 A NO 20030019A NO 20030019 A NO20030019 A NO 20030019A NO 20030019 L NO20030019 L NO 20030019L
Authority
NO
Norway
Prior art keywords
myeloma cell
cell line
human myeloma
human
producing
Prior art date
Application number
NO20030019A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030019D0 (no
Inventor
Abraham Karpas
Original Assignee
Univ Cambridge Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed by Univ Cambridge Tech filed Critical Univ Cambridge Tech
Publication of NO20030019D0 publication Critical patent/NO20030019D0/no
Publication of NO20030019L publication Critical patent/NO20030019L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20030019A 2000-07-07 2003-01-03 Human Myelom-cellelinje NO20030019L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (2)

Publication Number Publication Date
NO20030019D0 NO20030019D0 (no) 2003-01-03
NO20030019L true NO20030019L (no) 2003-03-07

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030019A NO20030019L (no) 2000-07-07 2003-01-03 Human Myelom-cellelinje

Country Status (12)

Country Link
US (1) US7387873B2 (enExample)
EP (1) EP1299524B1 (enExample)
JP (1) JP2004502454A (enExample)
KR (1) KR20030022850A (enExample)
CN (1) CN100497601C (enExample)
AT (1) ATE440945T1 (enExample)
AU (2) AU6930001A (enExample)
CA (1) CA2415484A1 (enExample)
DE (1) DE60139694D1 (enExample)
IL (1) IL153641A0 (enExample)
NO (1) NO20030019L (enExample)
WO (1) WO2002004607A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주
US7491530B2 (en) 2001-12-18 2009-02-17 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) * 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115161311B (zh) * 2022-08-22 2025-05-06 广东忠信生物科技有限公司 高效筛选分泌单克隆抗体的杂交瘤细胞的方法及其应用
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
KR20030022850A (ko) 2000-07-07 2003-03-17 캠브리지 유니버시티 테크니칼 서비스 리미티드 인간 골수종 세포주

Also Published As

Publication number Publication date
JP2004502454A (ja) 2004-01-29
ATE440945T1 (de) 2009-09-15
AU2001269300B2 (en) 2006-06-22
WO2002004607A1 (en) 2002-01-17
KR20030022850A (ko) 2003-03-17
US20040023339A1 (en) 2004-02-05
AU6930001A (en) 2002-01-21
CN1455813A (zh) 2003-11-12
CA2415484A1 (en) 2002-01-17
IL153641A0 (en) 2003-07-06
DE60139694D1 (de) 2009-10-08
US7387873B2 (en) 2008-06-17
CN100497601C (zh) 2009-06-10
EP1299524B1 (en) 2009-08-26
NO20030019D0 (no) 2003-01-03
EP1299524A1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
TR200300478T2 (tr) Hümanize antiLT-ß-R antikorları
EP1519747A4 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)
BR0209766B1 (pt) cÉlula combustÍvel com meios de gerenciar a hidrataÇço.
DE60115785D1 (de) Mit Wasserstoffverbrennung betriebene Heizungsanlage
EP1607404A4 (en) MONOCLONAL ANTIBODY AND HYBRIDOM THAT PRODUCES THIS
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
FR2810062B1 (fr) Serre horticole debachable
DE60112173D1 (de) Herstellungsverfahren für abzweigenden Stent mit verbesserter Nebenöffnung
ATE480564T1 (de) Monoklonaler anti-mensch-tenascin-antikörper
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
ATE382683T1 (de) Monoklonales antikörper gegen das hcv kernantigen
ATE440945T1 (de) Menschliche myelom zelllinie
BR0015872A (pt) Agentes antitrombóticos
EP1227159A4 (en) MONOCLONAL ANTIBODY, HYBRIDOMA, IMMUNITY TEST AND DIAGNOSTIC KIT
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
NO20022024D0 (no) Fremgangsmåte for å gjenta meldinger i lange intelligente kompletterings-systemlinjer
DK1263790T3 (da) Monoklonale antistoffer for den humane LDL-receptor, deres produktionsmetode og anvendelse
PL361803A1 (pl) Sposób zobojętniania popiołu, sztuczna pucolana otrzymana przy użyciu wymienionego sposobu
IS6716A (is) Aðferðir við að framleiða sílostasól
EP1556499A4 (en) FOR CARCINOGENIC BACTERIA SPECIFIC MONOCLONAL ANTIBODIES
NO20015285D0 (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler
MXPA02011391A (es) Modelo para enfermedad neurodegenerativa.
EP1483292A4 (en) WITH BACTERIAL COLLAGE-BINDING PROTEINS CROSS-REACTIVE MONOCLONAL ANTIBODIES
ATE535259T1 (de) Immunogener, monoklonaler antikörper
UA50030A (uk) Комплексне добриво

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application